» Articles » PMID: 15081534

Dendritic Cells in the Initiation of Immune Responses Against Central Nervous System-derived Antigens

Overview
Journal Immunol Lett
Date 2004 Apr 15
PMID 15081534
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Antigen presentation is essential for the activation and maintenance of antigen-specific T cell responses in the nervous tissue. Generally, it is becoming well accepted that the antigen presenting cell (APC) type responsible for the initiation of the primary immune response through the exclusive ability to activate naïve T cells is the dendritic cell (DC); however, the role of these cells in central nervous system (CNS) immunity is unclear at this time. The diverse phenotypes and origins of DCs make the characterization of their function in the CNS even more difficult. It is believed that DCs can influence the immune response in several ways: these cells are not only capable of initiating the immune response but they are also a major determinant of peripheral tolerance. DCs are characterized by the constitutive ability to express MHC class II molecules as well as high-level upregulation of these molecules in response to inflammatory stimuli. A pan DC marker that has proved to be useful in identifying them is CD11c (the alpha-chain of CR4); other markers include CD205 and MHC class II. DCs also actively participate in the humoral immune response. In this review, we would like to discuss how DCs appear in the CNS and their roles in initiation, maintenance and tolerance in the immune reactions in the CNS.

Citing Articles

Causal Relationship Between Post-Traumatic Stress Disorder and Immune Cell Traits: A Mendelian Randomization Study.

Wang J, Shao Y, Deng X, Du J Brain Behav. 2024; 14(10):e70073.

PMID: 39350630 PMC: 11443039. DOI: 10.1002/brb3.70073.


The Conventional Dendritic Cell 1 Subset Primes CD8+ T Cells and Traffics Tumor Antigen to Drive Antitumor Immunity in the Brain.

Bowman-Kirigin J, Desai R, Saunders B, Wang A, Schaettler M, Liu C Cancer Immunol Res. 2022; 11(1):20-37.

PMID: 36409838 PMC: 10725570. DOI: 10.1158/2326-6066.CIR-22-0098.


Dendritic Cell Vaccination of Glioblastoma: Road to Success or Dead End.

Datsi A, Sorg R Front Immunol. 2021; 12:770390.

PMID: 34795675 PMC: 8592940. DOI: 10.3389/fimmu.2021.770390.


Efficacy of the new therapeutic approach in curing malignant neoplasms on the model of human glioblastoma.

Dolgova E, Andrushkevich O, Kisaretova P, Proskurina A, Ritter G, Dubatolova T Cancer Biol Med. 2021; .

PMID: 34259424 PMC: 8330538. DOI: 10.20892/j.issn.2095-3941.2020.0511.


Neuroinflammation-Driven Lymphangiogenesis in CNS Diseases.

Hsu M, Laaker C, Sandor M, Fabry Z Front Cell Neurosci. 2021; 15:683676.

PMID: 34248503 PMC: 8261156. DOI: 10.3389/fncel.2021.683676.